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SUMMARY
Olfactory receptors (ORs) form a large family of
G protein-coupled receptor proteins (GPCRs)
responsible for sensing the ambient chemical envi-
ronment. The molecular recognition strategies used
by ORs to detect and distinguish odorant molecules
are unclear. Here, we investigated the variable of
odorant carbon chain conformation for an estab-
lished odorant-OR pair: n-octanal and rat OR-I7. A
series of conformationally restricted octanal mimics
were tested on live olfactory sensory neurons
(OSNs). Our results support a model in which unacti-
vated OR-I7 binds aliphatic aldehydes indiscrimin-
ately, and then applies conformational and length
filters to distinguish agonists from antagonists.
Specific conformers are proposed to activate OR-I7
by steric buttressing of an OR activation pocket.
Probing endogenously expressed rat OSNs with oc-
tanal and constrained mimics furnished evidence
that odorant conformation contributes to an odor-
ant’s unique olfactory code signature.
INTRODUCTION
The sense of smell begins with molecular recognition of a chem-
ical odorant by one or more olfactory receptors (ORs) expressed
in the olfactory sensory neurons (OSNs) of the nasal epithelium
(Firestein, 2001; Reed, 2004; Touhara, 2002). The ORs are
members of the G protein-coupled receptor (GPCR) family of
membrane-bound proteins (Buck and Axel, 1991). OR activation
by an odorant agonist initiates the transduction of chemical
structure information into a neural activity code that ultimately
gives rise to the perception of an odor. An odorant may also
bind an OR without triggering signal transduction, contributing
to the olfactory code by competitively antagonizing a receptor’s
activation by other odorant agonists present in a mixture (Ara-
neda et al., 2000, 2004; Oka et al., 2004). The rodent and human
genomes encode over 1000 ORs, though in humans many of
these are pseudogenes (Niimura and Nei, 2007). The combinato-
rial use of the set of ORs enables an individual to detect and
distinguish far more airborne chemicals than there are individual
ORs (Malnic et al., 1999; Oka et al., 2004).
Olfactory GPCRs have had to evolve to recognize small mole-
cules that disperse into the air. Hence, odorants are typically low
molecular weight and uncharged. Many odorants are hydrocar-
bons or very hydrophobic molecules containing a single hetero-
atom, most often oxygen. Many olfactory GPCRs must conse-
quently bind odorants without the benefit of multiple polar
interactions common to other small molecule-protein associa-
tions such as enzyme-substrate associations, or those pertain-
ing to the aminergic GPCRs (Shi and Javitch, 2002). Like
rhodopsin and other class A GPCR family members, ORs are
predicted to have seven transmembrane (TM) a helices and to
bind their ligands in a site bounded by TMs 3, 5, 6, and possibly
4 and 7 (Abaffy et al., 2007; Hall et al., 2004; Katada et al., 2005;
Pilpel and Lancet, 1999; Singer, 2000). ORs exhibit a high degree
of sequence variability within these helices as expected for
a family of proteins that binds diverse ligands. In the hypervari-
able TM regions where contact with odorants is predicted to
occur, there is a strong bias toward hydrophobic aliphatic and
aromatic residues, a weaker bias toward polar uncharged resi-
dues, and a bias against charged residues (Pilpel and Lancet,
1999). Difficulties obtaining atomic level structural information
on transmembrane proteins have prevented a detailed under-
standing of the strategies used by olfactory GPCRs to discrimi-
nate their odorant ligands.
It has long been known that a single OSN can be activated by
a range of related odorants (Firestein et al., 1993; Ma and Shep-
herd, 2000; Sato et al., 1994; Sicard and Holley, 1984). Evidence
continues to accrue in support of the idea that each OSN
expresses only one of its 1000 genomic ORs (Chess et al.,
1994; Malnic et al., 1999; Serizawa et al., 2004). It follows that
each OR must be able to recognize multiple odorants. This has
been demonstrated experimentally, though the structural relat-
edness of the activating odorants varies from receptor to
receptor (Araneda et al., 2000; Kaluza and Breer, 2000; Kraut-
wurst et al., 1998; Malnic et al., 1999; Raming et al., 1993; Tou-
hara et al., 1999; Zhao et al., 1998). Perhaps to ensure surveil-
lance of as much chemical space (Dobson, 2004) as possible,
the receptive ranges of ORs overlap, with a single odorant typi-
cally activating multiple ORs. Different odorants, even those that
are structurally related, appear to activate unique subsets of
ORs, ultimately giving rise to a unique olfactory experience and
forming the basis of the olfactory code (Malnic et al., 1999).Chemistry & Biology 15, 1317–1327, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1317
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Odorant Conformation and Receptor ActivationTo understand the olfactory code at the chemical level will
require a precise understanding of the chemical determinants
responsible for activating and blocking each OR. Several studies
have cited molecular ‘‘length’’ as one such determinant (Araneda
et al., 2000; Ho et al., 2006; Kaluza and Breer, 2000; Malnic et al.,
1999; Mori et al., 1999). Length studies have focused mainly on
odorants containing aliphatic carbon chains (Araneda et al.,
2000; Ho et al., 2006; Kaluza and Breer, 2000; Malnic et al.,
1999). These studies used homologous series of conformation-
ally flexible n-alkyl acids, aldehydes, ketones, and alcohols.
However, the conformational flexibility of such odorants leaves
unclear the true molecular length required for activation because
aliphatic odorants exist in large ensembles of conformational
isomers. This uncertainty also raises the question whether ORs
bind odorants in preferred conformations—such as an extended
conformation, as implied in the previous studies—but disfavor
the same odorants when presented in other conformations.
Moreover, GPCR binding and GPCR activation may have
different conformational requirements. To address the variable
of odorant conformation as a factor in the molecular receptive
range of a representative OR, we have assayed a series of con-
formationally restricted analogs of octanal, the primary agonist
for the rat I7 olfactory receptor (OR-I7). Testing these
compounds has provided insight into the activation and blocking
of the OR-I7 receptor, and has demonstrated how conforma-
tional flexibility influences the total number of ORs activated by
a single odorant.
RESULTS
The rat OR-I7 receptor is one of the few ORs to have been
cloned, expressed in neurons, and functionally characterized
by probing with a large collection of odorants (Araneda et al.,
2000, 2004; Krautwurst et al., 1998; Zhao et al., 1998). OR-I7 is
activated by multiple aliphatic aldehydes having a length
between 8 A˚ and 12 A˚ (Araneda et al., 2000). We note that
multiple conformations are possible for aliphatic aldehydes.
We therefore define length here to mean the length of the longest
attainable (and typically lowest energy) conformation (see
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Figure 1. Conformationally Restricted
Octanal Analogs
(A) Lengths refer to the distance measured from
the carbonyl carbon to the most distant carbon
as described in Experimental Procedures.
(B) Synthetic routes to compounds 1–6. See
Supplemental Data for details.
Experimental Procedures). The most
potent OR-I7 ligand found thus far is oc-
tanal, referred to hereafter as C8 (for 8
carbon n-alkanal; likewise for C7, C6,
etc.). Like many ORs, OR-I7 is activated
by odorants with successive carbon
chain lengths centered on the most
potent ligand (Kaluza and Breer, 2000;
Malnic et al., 1999). In the rat nasal
epithelium, C8 activates more cells and
elicits a greater cAMP (the signal transduction second
messenger) response than do shorter and longer homologs (Ka-
luza and Breer, 2000), indicating that the dimensions of the OR-I7
binding site are likely close to average. OR-I7 is thus typical and
well characterized, ideal for a systematic investigation of the
effect of odorant conformation on its receptive range.
A Series of Conformationally Restricted Eight-Carbon
Aldehydes
C8 is highly flexible, having six rotatable bonds that can each
adopt three different conformations: one anti, or one of two
gauche. The maximum number of formally possible conforma-
tional isomers is 36 = 729, though symmetry makes some equiv-
alent and undoubtedly reduces this number. Nothing is known
about the bound conformation of C8. On the one hand, were
C8 to bind and activate OR-I7 in one or a small subset of favored
conformers, it would incur a conformational entropy penalty in
the free energy of binding due to the loss of conformational flex-
ibility. In this case, preorganizing C8 to resemble the bound
conformation should improve binding by minimizing the loss of
entropy. On the other hand, a previous study compared the
calculated lowest energy conformation of a group of activating
ligands and concluded that OR-I7 may tolerate a number of
structural variations at the carbons most distant from the alde-
hyde (Araneda et al., 2000), possibly indicating that many
different C8 conformers are capable of activating OR-I7. To
gain insight into the activating conformation(s) of C8, we made
a series of eight-carbon aldehydes with restricted conformations
(Figure 1A). Conceptually, carbon 8 (denoted as C8) of C8 was
tied back by establishing a new bond successively to C7 through
C2, yielding compounds 1–6, respectively. Unlike the previously
studied series of homologous n-alkanals, in which the partition
coefficient and other physical properties can vary with the
number of carbons in the chain, we expect to maintain
throughout our eight-carbon series similar physical-chemical
properties while reducing the number of possible conformations.
This strategy should enable us to study effects that occur at
the level of the OR binding pocket while minimizing receptor-
independent effects. In this series the maximum length of the1318 Chemistry & Biology 15, 1317–1327, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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Odorant Conformation and Receptor Activationaldehydes is also progressively shortened. Due to the conforma-
tional restriction, the maximum length is now a better estimation
of this dimension compared with the n-alkanal series. The
synthesis of these analogs was straightforward and is summa-
rized in Figure 1B.
OR-I7 Activation: Octanal Uses a Semi-Extended
Conformation
The eight-carbon aldehydes were tested via calcium imaging of
dissociated rat neurons expressing recombinant OR-I7 from an
adenoviral vector as previously described (Araneda et al.,
2004). As an example, the activation of OR-I7 by analog 3 is
shown in Figure 2A. Responses were concentration dependant
and saturating. At high concentrations, the magnitude of the
response to analogs 1, 2, and 3 saturated with efficacies compa-
rable to that of C8; no partial agonists were detected. Analogs 4,
5, and 6 failed to reach saturation over this concentration range.
Activation curves for the entire series, including C8, are shown in
Figure 2B, which also tabulates the concentrations at which half-
maximal activation is reached (EC50). The compounds segregate
into two groups. Compounds 1, 2, and 3, which have smaller
rings and four to six freely rotatable bonds, all strongly activated
OR-I7, whereas compounds 4, 5, and 6, which contain larger
rings and one to three rotatable bonds, activated OR-I7 weakly
or not at all. The greatest difference in activity, 163-fold, was
observed between compound 4 (6.3 A˚, EC50 = 748 mM) and
compound 3 (7.0 A˚, EC50 = 4.6 mM). The n-alkanals of 5–12
carbons (C5–C12) were previously tested against OR-I7 in the
vapor phase using electroolfactogram (EOG) recordings (Ara-
neda et al., 2000; Zhao et al., 1998). By that method, the largest
difference in activity in the series fell similarly between C6, (no
activation, 6.4 A˚) and C7 (activation, 7.6 A˚). Thus, using the
new series of C8 analogs, we confirmed that there is a minimum
length requirement for activation, and further narrow it down
from 6.4–7.6 A˚ to 6.5–6.9 A˚. We interpret the finding that an alde-
hyde of only 7.0 A˚ is sufficient to activate the receptor, compared
with the extended length of C8 (8.9 A˚), to mean that C8 does not
activate OR-I7 in its fully extended conformation, but rather
adopts one or more semiextended conformations to do so.
The poor activity in the eight-carbon aldehydes 4–6, where the
variables of total carbon number and length are separated,
defines the shorter end of the activating length cutoff, and
provides evidence that C8 does not activate OR-I7 while in
compact conformations approximating those mimicked by 4–6.
Small Cycloalkyl Rings Enhance OR-I7 Activation
To test whether maximum length is solely responsible for the
difference in activity observed among compounds 1–6, we ob-
tained the full activation curves for C7 and C6 by calcium
imaging (Figure 3). Although C7 and compound 2 have identical
extended lengths, 2 was 40-fold more potent (Figure 3A).
Compound 2 was even more potent than C8.
Similar to previous OR-I7 EOG recordings (Araneda et al.,
2000), calcium imaging revealed a sharp increase in activity
(145-fold) in the step from C6 to C7 (Figure 3B). The maximum
length of compound 3, which contains the cyclobutyl group, falls
between those of C7 and C6 (Figure 3C). Based on a correlation
with maximum length, the activity of 3 should also fall between
that of C7 and C6. However, 3 was more potent than both
(Figure 3B), providing a second example where a small
cycloalkyl ring increased potency beyond what was expected
based on length alone. Thus, though the activity of the cyclic
compounds generally required a certain minimum length, re-
stricting the rotation of the terminal two or three bonds enhanced
potency, indicating that specific conformations or shapes at the
end opposite the aldehyde are preferred by the activating form of
OR-I7.
An Activating Octanal Conformation
We next explored conformational restriction of C8 toward the
middle of the chain. In examining the data shown in Figure 2B,
we noted that all of the active compounds had a rotatable
bond between C4 and C5, whereas in all inactive compounds
this bond was locked in a ring. Although this observation might
merely reflect the variable of length, in another study the
same bond in trans-2-cis-6-nonadienal, an OR-I7 activating
compound, was implicated as a potential pivot point important
for activation (Araneda et al., 2000). In the extended
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Figure 2. OR-I7 Activation by Cyclic Octanal Analogs
(A) Calcium imaging traces from a GFP+ OSN, showing how OR-I7 responds at a near saturating level to 30 mM of compound 3 but is unresponsive to compound 4
at the same concentration. Grey dashed line denotes baseline; black dashed line denotes a trend line for normalization (see Experimental Procedures).
(B) Activation dose-response curves for the cyclic compound series (open symbols). The activation dose-response curve for octanal (C8) is also provided for
reference (filled symbol). Octanal and compounds 1–3 are saturated over this range and thus normalized to their respective maximal responses. Compounds
4–6 are shown normalized to the response to 10 mM octanal. The maximal efficacies for each compound, relative to 10 mM 1, were as follows (mean ± SEM):
2, 0.99 ± 0.02; 3, 1.06 ± 0.1; C8, 0.89 ± 0.02; and C7, 0.86 ± 0.07. Data point error bars represent ±SEM; EC50 ± SD.
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Odorant Conformation and Receptor Activationconformation, all of C8’s C-C bonds adopt the anti conformation
(Figure 4A, left). Rotation of the C4-C5 bond by 120
 into a gauche
conformation (Figure 4A, middle) reduces the total length of C8
from 8.9 A˚ to 8.0 A˚, provided the other bonds remain in the
anti conformation. Changes of this nature could serve to reduce
the actual length of the molecule into the type of semiextended
conformation proposed herein. To test the effect of this partic-
ular alteration, we installed a two-carbon bridge from C3 of C8
to C6 (Figure 4A, right). The resulting six-member ring locked
C8 into a gauche conformation around C4-C5. Imagining this
process beginning with a rotation of the same bond in the oppo-
site sense produces the same structure, due to symmetry.
Compared with the 729 hypothetical conformations that C8
can sample, the resulting C8 analog, 11, can exist in only 10
closely related conformers. 11 was synthesized as a 2.4:1
mix of the trans:cis isomers, as outlined in Figure 4B and
described in Experimental Procedures.
Unable to separate these two isomers, we tested 11 as
a mixture. In the case where one isomer is inactive—or perhaps
even an antagonist—testing the mixture incurs the risk of
underestimating the true response of the other isomer. Despite
this concern and the introduction of a six-member ring into the
middle of C8, the isomeric mixture of 11 was more active than
C8, shifting the activation curve slightly to the left (Figure 4C).
Just as C8 is two carbons longer than the much less potent
C6, compound 11 is two carbons longer than the nearly inac-
tive 5, and the gain in activity might appear to correlate merely
with the increase in extended conformation length (the cis
isomer of 11 is 7.4 A˚ and the trans is 8.0 A˚). However, in
contrast to C8, the two terminal carbons of 11 are fixed by
the ring in their relation to the aldehyde group, though in slightly
different locations in the two isomers. If we assume that the
orientation of the aldehyde group with OR-I7 is fixed in the
odorant binding site, then the three-dimensional coordinates
of the ethyl group of 11 must likewise be fixed and occupy
a distal (to the aldehyde) activating region in the receptor. 11
may therefore resemble an, or the, activating conformation of
C8, just as 4, 5, and 6 are constrained to resemble inactive
conformations.
Conformational Determinants of OR-I7 Antagonism
In nature, odorants are typically encountered in mixtures. In this
context, each odorant can activate one set of receptors while
simultaneously antagonizing a subset of receptors activated by
other components, leading to great complexity in the olfactory
code at the level of sensory input (Araneda et al., 2000, 2004;
Malnic et al., 1999; Oka et al., 2004). Most OR antagonists
discovered to date are structurally related to the agonists whose
activity they suppress (Araneda et al., 2000, 2004; Oka et al.,
2004). Interestingly, natural product fragrances typically contain
structurally related odorants (Arctander, 1960), suggesting
a potential evolutionary significance.
We thus set out to systematically probe the length and confor-
mation requirements for antagonism of OR-I7 by simultaneously
applying a saturating concentration of C8 (10 mM) and increasing
concentrations of either the inactive C8 analogs 5 and 6 or the
similarly inactive C4 and C5. The marginally active C6 and 4
were also used. Unexpectedly, nearly all were capable of antag-
onizing C8 activation, suggesting a broad antagonist receptive
field with regard to the hydrophobic portion of short aldehydes.
A representative calcium imaging trace is shown in Figure 5A.
Here, analog 6, which itself cannot activate OR-I7, is shown to
antagonize C8 activity. Inhibition curves for 4, 5, 6, C4, C5,
and C6 are shown in Figure 5B with the concentration of each
required for 50% inhibition (IC50) tabulated in Figure 5C. Among
the n-aldehydes, antagonist potency increased with the number
of carbons in the chain. The failure of C4 (3.9 A˚) to antagonize C8
activation may indicate a minimum n-aldehyde chain length
requirement for antagonism between 4.0 A˚ and 5.1 A˚, but we
cannot rule out receptor-independent effects, such as reduced
hydrophobicity and increased water solubility due to the small
size. Among the cycloalkyl ring-containing aldehydes, where
the constant number of carbons should control for receptor-
independent effects, all were moderate antagonists but without
apparent length dependence (Figure 5C). In fact, the IC50s for
the cyclic compounds were remarkably similar and each was
a more potent antagonist than its closest length-matched
n-alkanal. This result may indicate a dependence of antagonism
on odorant surface area or carbon number in combination with
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(A) Activation dose-response curves for cyclic
compound 2 (open circles) and the n-aldehyde
of identical length, C7 (filled circles). Data point
error bars represent ±SEM.
(B) Activation dose-response curves for cyclic
compound 3 (open squares) and the n-aldehydes
of flanking lengths C7 (filled circles) and C6 (filled
diamonds). Data point error bars represent ±SEM.
(C) Summary of maximal lengths and EC50 of
activation for the strongly activating cyclic and
n-aldehydes. The relative activation of C8 and
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Odorant Conformation and Receptor Activationa maximum length below 6.5–6.9 A˚. Taken together with the acti-
vation data, aldehydes that resemble C8 in a compact conforma-
tion appear to be able to bind OR-I7 in its unactivated state,
blocking subsequent activation by C8, whereas those that can
extend beyond 6.5–6.9 A˚ appear able to bind and stabilize
OR-I7 in its activated state. Held close to the aldehyde, the large
cycloalkyl groups appeared to enhance antagonism, just as the
small cycloalkyl rings, held distant, enhanced activation. Overall,
these results provide an example where a structural trait, namely
maximum attainable length, is correlated in a systematic way
with the transition from antagonism to agonism.
Functional Group Determinants of OR-I7 Antagonism
The strict requirement of an aldehyde group for activation of
OR-I7 is well established (Araneda et al., 2000). The results
described herein prompted us to ask whether antagonism also
requires the aldehyde group. As shown in Figure 5D, replace-
ment of the aldehyde function in C6 with a variety of other func-
tional groups resulted in loss of antagonism. In combination with
the activation data, this result means that the aldehyde group is
necessary but not sufficient for binding to OR-I7. The attributes
of the carbon chain complete the requirements for binding and
determine whether binding leads to activation or antagonism.
Conformational Flexibility Contributes to the Activation
Range of an Odorant
OR-I7 is not the only C8 receptor in the rat genome; C8 is esti-
mated to activate between 55 and 70 of the 1227 predicted
(Gibbs et al., 2004) functional rat ORs (Araneda et al., 2004). It
has long been suspected that highly flexible odorants activate
more ORs than do less flexible odorants (Amoore, 1970; Kaluza
and Breer, 2000). However, this possibility has previously only
been examined using a series of odorants that vary in carbon
number and thus in multiple physical properties (Kaluza and
Breer, 2000). Our series of conformationally restricted C8
analogs provided the opportunity to examine this question in
a controlled manner, using C8 as a representative odorant.
We assayed 1190 viable rat OSNs with 30 mM C8 and (individ-
ually) analogs 1–6. The cells were also probed with forskolin, an
activator of the signal transduction cascade that bypasses the
OR to provide an internal standard for normalization of the
OSN response to each odorant. Figure 6A represents the entire
population of cells that responded to at least one compound,
showing how each cell discriminated among the eight-carbon
aldehydes. The activation traces of three representative cells
are shown in Figure 6B. Overall, 5.9% of OSNs (70/1190) were
activated to some extent by C8, in close agreement with the
earlier study (Araneda et al., 2004). C8 and the less constrained
(more rotatable bonds) analogs 1, 2, and 3 activated approxi-
mately twice as many cells as did the most constrained analogs,
5 and 6 (Figure 6C, filled circles; 5.6%, 6.2%, and 6.2% versus
3.4% and 3.6%, respectively). These data support the idea
that, in general, the greater the flexibility of an odorant, the
greater the number of ORs it will activate, even when the odor-
ant’s functional groups and number of carbons are held
constant.
With the exception of one cell (Figure 6A, cell 53), all C8-sensi-
tive cells also responded to at least one of the cyclic analogs,
consistent with the idea that our analogs sample subregions of
the conformational space occupied by the ensemble of C8
conformers detected by OSNs. None of the cells activated by
C8 responded equally to all analogs, which we interpret as
evidence that conformational preference is a general underlying
feature among C8-responding ORs, and not unique to OR-I7.
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Data point error bars represent ±SEM; EC50 ± SD.Chemistry & Biology 15, 1317–1327, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1321
Chemistry & Biology
Odorant Conformation and Receptor ActivationOf the 70 cells that responded to C8, 39 (56%) responded more
strongly to a cyclic analog than to C8. This high percentage was
unexpected because C8 is the only natural product in the series.
One explanation is that for these OSNs, the most strongly acti-
vating cyclic analog is preorganized into a region of C8’s confor-
mational space that binds and stabilizes the activating form of
the single ORs expressed in these cells, so that less conforma-
tional entropy is lost upon activation. The overall free energy of
binding should become more favorable and lead to greater
potency versus C8. For each OSN that preferred a cyclic analog
to C8, we calculated the difference in the normalized response
magnitudes between its best-tuned analog (i.e., the most highly
activating analog) for the OSN and that of C8 (Figure 6D). Orga-
nizing the data in this way revealed a clear trend in which the
difference in activation grew as the analogs became more con-
formationally restricted (fewer rotatable bonds). The more con-
formationally restricted compounds 5 and 6 may be viewed as
frozen in conformations that mimic relatively high-energy, rarely
populated conformations of C8. The difference in strength of
activation shown in Figure 6D should reflect both the preorgani-
zation inherent in the analog and the difficulty C8 has in adopting
the conformation preferred by these OSNs. Rings are common in
natural product odorants. Ring-containing odorants may
achieve some of their odorant qualities by simulating conforma-
tions rarely adopted by acyclic compounds that otherwise
contain a similar number of carbons and the same functional
groups.
DISCUSSION
Rhodopsin, the most frequently studied GPCR, evolved to
respond to photons, but its activation is in fact triggered by the
isomerization of a covalently held ligand (Sakmar et al., 2002).
We consider this isomerization to be analogous to a conforma-
tional change, though one that depends on light. From this
perspective, rhodopsin can be considered to exemplify the
importance of ligand conformation to GPCR activation. ORs,
which like rhodopsin belong to the class A GPCR subfamily,
have evolved to report on the chemical space of airborne mole-
cules. An important variable in chemical space is shape, which in
molecules with rotatable bonds is determined by conformation.
Flexible molecules constantly change conformation, but to
respond to all possible odorant conformations would be a strin-
gent demand to place on an OR, which needs to maintain
a degree of tuning specificity to contribute to the olfactory
code. It is reasonable then to expect that molecular conforma-
tion is an important determinant of the receptive range of ORs
and that, like rhodopsin, ORs will be stabilized in their activated
and unactivated states by specific but divergent odorant confor-
mations. The prevalence of carbocyclic rings in distinctive
fragrance molecules, such as the santalols and terpenoids,
among many others, reinforces this expectation. However, the
difficulty in obtaining structural information on membrane-bound
proteins has made this expectation impossible to verify experi-
mentally.
We chose OR-I7 to investigate the importance of conformation
to OR activation because it can be expressed recombinantly in
OSNs and because its primary ligand, C8, has many rotatable
bonds that can be selectively restricted in synthetic analogs de-
signed to address specific hypotheses. In the C8 analogs pre-
sented here (Figure 1A), we chose to begin by keeping the
number of carbons constant. This choice enabled us to progres-
sively restrict the rotatable bonds of C8 and to systematically
shorten its length while maintaining similar physical properties
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Figure 5. Inhibition of OR-I7 Activation by
Short Octanal Analogs
(A) Calcium imaging traces from a GFP+ OSN
showing the dose-dependent antagonism of
compound 6 against a saturating dose of octanal.
Black arrowheads denote the application of
10 mM octanal either with or without coapplication
of 6 (open arrowheads). The black dashed line is
the trend line, indicating the predicted response
magnitude if the coapplication had no effect.
(B) Inhibition dose-response curves for cyclic
analogs and n-aldehydes of similar lengths, tested
at various concentrations against a 10 mM octanal
stimulus. The cyclic compounds (open symbols) all
display very similar potencies regardless of length,
whereas the n-aldehydes (filled symbols) show
length dependence for antagonism. Dashed lines
indicate extrapolation used to estimate IC50. Data
point error bars represent ± SEM.
(C) Summary of maximal lengths and IC50 values
for the antagonizing aldehydes. IC50 ± SD.
(D) An aldehyde group is required for OR-I7 antag-
onism. Nonaldehydes of similar size were unable to
antagonize octanal activation of OR-I7. Dashed
line indicates 90% of the signal produced by
10 mM octanal alone. Error bars represent ± SEM.1322 Chemistry & Biology 15, 1317–1327, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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Odorant Conformation and Receptor Activationsuch as lipophilicity. Using this series, we confirmed that molec-
ular length is important to activity when the number of carbons is
held constant (summarized in Figure 7A): aldehydes 1, 2, and 3
activated OR-I7, but 5, 6, and, for the most part, 4 were too short
to activate it, even though competition experiments demon-
strated that they bound OR-I7. A previous rat OR-I7 study using
n-alkanals had noted that C8’s activity was greater than that of
C7, and that C6 was inactive (Araneda et al., 2000). We noted
a similar trend here (Figure 7A) using a different method that
permitted greater control over the concentration of applied
odorant. The finding here and elsewhere (Araneda et al., 2000)
that C7 (7.6 A˚) produces significant OR-I7 activity can be taken
as evidence that C8 need not adopt its longest possible (and
lowest energy) conformer (8.9 A˚) to activate OR-I7. The potent
activity of C8 analogs 2 (7.6 A˚) and 3 (7.0 A˚) further support the
idea that C8 activates OR-I7 in a shorter-than-extended confor-
mation. The inability of the eight-carbon aldehydes 5 (5.4 A˚), 6
(4.7 A˚), and, with the exception of very high concentrations, 4
(6.3 A˚) to activate OR-I7 indicates, however, that extreme devia-
tions from the extended conformation are inconsistent with acti-
vation, though not binding. This finding appears to rule out the
possibility that OR-I7 is activated by tightly bent C8 conformers
resembling those mimicked by 4–6. OR-I7 appears therefore to
be activated by C8 in a conformation whose length falls in
a window somewhere between its extremes.
The restricted C8 analogs also revealed that odorant length is
not the sole characteristic of the carbon chain that determines
OR-I7 activity. Within the window of activating lengths, the
activity of compounds 2 and 3 was anomalously high when
compared with the n-alkanal series. For example, C7 and 2
have the same maximum length, yet 2 was 40-fold more potent.
This anomaly indicates that the rotational restriction of the last
two or three carbons of a sufficiently long aldehyde enhanced
its ability to activate OR-I7. OR-I7-activating aldehydes were
previously thought to be insensitive to structural variability in
this region because the predicted lowest energy conformations
of a group of activating ligands showed variability there but not
in the proximal C1–C4 region (Araneda et al., 2000). Our results
using restricted eight-carbon aldehydes show that terminal cy-
clopropyl and cyclobutyl groups can be potent substructures
for OR-I7 activation. We speculate that the terminal methyl
group in C8 and C7 can rotate away from a distal activating
hydrophobic binding pocket through rotation of the C5-C6 or
C6-C7 bonds, whereas in 2, the analogous bonds are fixed by
the cyclopropyl ring, perhaps forcing a portion of the ring to
persist in contact with the pocket. (C6 apparently reaches this
hypothetical binding pocket much less efficiently.) In this regard,
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Figure 6. Conformational Preference among Octanal Receptors
(A) Response profiles of the entire population of OSNs activated by 30 mM oc-
tanal (C8) or the cyclic analogs 1–6 out of 1190 tested OSNs. Only responding
cells are represented. Response strength was normalized within each cell to
10 mM of the adenylate cyclase activator, forskolin, to gauge near maximal
activation of the signal transduction cascade. The compound eliciting the
greatest response by the cell (i.e., its preferred tuning) is denoted by a white
dot.
(B) Representative calcium-imaging traces from three selected cells exposed
to aldehydes 1–6, each given individually at 30 mM. Compounds were tested in
random order but rearranged for presentation clarity. The open arrowheads
denote application of the DMSO vehicle (d) or forskolin (fork).
(C) Percentages of OSNs responding to 30 mM of the indicated compound
among the 1190 tested cells (filled circles) and percentages of cells preferen-
tially tuned to the indicated compounds (open circles).
(D) Average difference in activation strength between analogs and octanal. For
the cells whose preferred tuning included a cyclic analog, the response to oc-
tanal was subtracted from the response to the preferred analog. This differ-
ence was then averaged over all cells tuned to that same analog. Because
all responses are normalized within each cell to forskolin activation, the
maximum possible difference is 1.0 (i.e., the case where a cell responds as
robustly to the preferred analog as forskolin but fails entirely to respond to
octanal).
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Odorant Conformation and Receptor Activationthe receptive range of OR-I7 appears to be fine-tuned through
the application of length and conformational filters, as the
receptor binds a wider range of aldehydes than can proceed
to activation.
What, then, is the activating C8 conformation of OR-I7, and
how does it stabilize activation? Using our activation data and
information from a previous study (Araneda et al., 2000), we
focused on the conformation around the C4-C5 bond. A 120

rotation of this bond from the more stable anti to the less-stable
gauche conformation shortens and kinks the chain slightly.
When locked into this conformation, the resulting C8 analog 11
was more active (as a cis/trans mixture) than C8, despite the
extra steric bulk of the two-carbon bridge. The closer of these
two bridging carbons resembles a 3-methyl group, which in
the context of similar aliphatic aldehydes is well tolerated by
OR-I7 (Araneda et al., 2000). Unlike the acyclic aldehydes, the
stereochemical relationship between the aldehyde and the last
two carbons of 11 is fixed by the ring to a small number of confor-
mations. Because activity was preserved we conclude that 11
resembles an activating conformation of C8. Separate testing
of the cis and trans isomers, and the synthesis of other analogs
restricted in this part of 11, will tell us if it resembles the only acti-
vating conformer, or if OR-I7 tolerates some conformational
heterogeneity here.
A comparison of 11 to compound 5 is also informative
(Figure 4C). Compound 5 lacks the ethyl group of 11 but is other-
wise identical. The addition of this ethyl group to 5 was sufficient
to convert it from an antagonist into an agonist of greater potency
than C8. The ethyl group is therefore responsible for activation,
though not for binding, and must somehow stabilize an activated
conformation of OR-I7. It is unlikely that the ethyl group directly
adds to the enthalpy of binding the activated OR-I7 because it
cannot form hydrogen bonds or engage in other polar noncova-
lent interactions with the receptor. Nevertheless, the ethyl group
triggers activation. One explanation is that the last two carbons
of 11, analogous to those of C8, fit into a hydrophobic pocket
of the active form where they function as a steric buttress to
prevent OR-I7 from reverting to inactive forms (Figure 7B). This
pocket may be closed off in the inactive forms of OR-I7. Because
most odorants are hydrophobic, the steric buttress effect may be
a general means of stabilizing activated OR forms, as it does not
require a polar interaction between the OR and odorant, but can
nonetheless generate binding enthalpy by the formation of new
intramolecular contacts within the reorganized and activated
OR (Kobilka and Deupi, 2007).
Our finding that tightly bent C8 analogs bind OR-I7 silently
suggests that OR-I7 does not use conformational selection to
bind only activating conformers of C8, but rather that OR-I7
can bind C8 in many conformations. Proceeding to receptor acti-
vation, however, appears to require a double-induced fit, with
the agonist unfurling or kinking, as the case may be, to adopt
a specific semiextended conformation that stabilizes the acti-
vated form of the receptor. Thus, to be an OR-I7 agonist, an alde-
hyde must be capable of adopting a conformation in which it can
simultaneously plug into two pockets, one specific for the alde-
hyde functional group and one about 7 A˚ away having some pref-
erence for small hydrophobic rings. The intervening carbons
appear to add binding energy, though to be an agonist, C2-C3
must not be substituted when doubly bonded, as previously
found (Araneda et al., 2000).
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Odorant Conformation and Receptor ActivationMatching an OR with an activating odorant is the first step
toward understanding the structural basis of an OR’s contribu-
tion to the olfactory code. Once a ligand is identified,
rhodopsin-based homology modeling can be used to formulate
a structural hypothesis for the interaction. Several groups have
recently used site-directed mutagenesis within the transmem-
brane regions to experimentally test predicted odorant-OR inter-
actions (Abaffy et al., 2007; Katada et al., 2005; Schmiedeberg
et al., 2007). These studies have obtained experimental support
for rhodopsin-based structures, and have generated insightful
details into the nature of the OR’s binding site. Based on our
work, we propose that for ligands with rotatable bonds there
will exist conformations favored by the activated and inactive
forms of the OR. Experimental evaluation of conformationally
restricted odorant analogs may therefore improve homology
modeling, as the agonist can be kept in the preferred conforma-
tion during the modeling process.
It is not yet clear how many ORs are typically activated by
a single odorant, though this question is fundamental to under-
standing the olfactory code. It has been suggested that flexible
odorants can activate more ORs than do constrained odorants
(Amoore, 1970; Kaluza and Breer, 2000). Our series of eight-
carbon aldehydes enabled us to study this question in a
controlled manner, and we found that there was a correlation
between greater flexibility and the percentage of OSNs activated.
Furthermore, we found that a high percentage of C8-responding
OSNs were activated more potently by conformationally
restricted C8 analogs than by C8 itself, indicating that many
C8-detecting ORs, and not just OR-I7, possess some sort of
conformational filter. Thus, in analogy to rhodopsin, many ORs
appear to be activated or antagonized by specific ligand shapes,
even though the ligand may adopt multiple forms (isomers or
conformations). The conformationally restricted rings often found
in natural fragrance molecules may mimic subsets of conforma-
tions in related but more flexible odorants. Some of these
mimicked conformers may be high energy and rare, thus contrib-
uting to uncommon signatures in the olfactory code.
SIGNIFICANCE
The molecular recognition of airborne chemicals is chal-
lenging because volatility requires low molecular weights
and a minimum or absence of polar functional groups, yet
this is the subset of chemical space that the olfactory recep-
tors (ORs) have been charged by evolution to monitor.
Nearly all odorants have rotatable bonds and can adopt
multiple conformations. In a representative system, we
have investigated the variable of octanal conformation as
a molecular determinant of OR-I7 activation and antago-
nism. We show that OR-I7 binds a variety of aliphatic alde-
hydes, but then applies length and conformational criteria
that lead either to activation (longer than 6.5–6.9 A˚) or antag-
onism (shorter than 6.5–6.9 A˚). Using a series of octanal
mimics, we chart the transition from antagonism to agonism
as a function of increasing length. For octanal, the apparent
primary agonist for this receptor, we deduce that long and
short conformers bind the resting state of OR-I7 and,
through a double-induced fit, cooperate to produce the acti-
vating odorant-OR pair. In mixtures, various OR-I7-bound
aldehydes, whether activating or antagonizing, contribute
to the olfactory code either positively or negatively, enabling
I7 to respond in a gradual manner to mixtures of aliphatic
aldehydes rather than to only the best-tuned ligands. By
studying nearly 1200 rat olfactory sensory neurons (OSNs),
we find evidence that the molecular conformation of flexible
odorants appears to be a common determinant of activa-
tion, and that fewer OSNs are tuned to rare conformers.
For OR-I7, we also find that small cycloalkyl groups at the
distal end of an aldehyde enhance activation potency. We
propose that they fit into and buttress a small hydrophobic
pocket present only in the activated form of the receptor,
sterically preventing reversion to the unactivated form. The
steric buttress may be a common strategy for recognizing
nonpolar odorants, such as the hydrocarbons.
EXPERIMENTAL PROCEDURES
Method to Estimate the Maximum Extended Length of Aldehydes
Chem3D Ultra 10.0 software (CambridgeSoft; Cambridge, MA) was used. The
structure of the aldehyde was drawn in its most extended conformation. The
energy was minimized using the MM2 force field. The length was then
measured from the carbonyl carbon to the most remote carbon.
Synthesis of Octanal Analogs
See Supplemental Data available online for detailed synthetic procedures and
compound characterization.
Isolation of Olfactory Sensory Neurons
All animal procedures were approved by the Columbia University Institutional
Animal Care and Use Committee and performed at Columbia University in
compliance with relevant national guidelines and regulations. Procedures for
isolating rat OSNs were performed as described in detail elsewhere with minor
modifications to the dissociation solution (Araneda et al., 2004). For OR-I7
experiments, male Sprague-Dawley rats 6–7 weeks old were infected with
an adenovirus that encoded OR-I7 and GFP as separate proteins (Zhao
et al., 1998). Two to 3 days following infection, regions of the olfactory epithe-
lium exhibiting dense GFP fluorescence were dissected out. For the panel
screening in Figure 6, uninfected rats were used, and the entire olfactory
epithelium was collected. The olfactory epithelium was dissected free from
the underlying bone under chilled divalent cation-free Ringer (145 mM NaCl,
5.6 mM KCl, 10 mM HEPES, 10 mM glucose, and 4 mM EGTA [pH 7.4]),
minced, and then incubated for 45 min in 2.5 ml of divalent cation-free Ringer
containing 5 mg/ml bovine serum albumin (B4287; Sigma-Aldrich; Milwaukee,
WI), 1 mg/ml collagenase (17100-017; GIBCO; Carlsbad, CA), 2.4 U/ml dis-
pase II (04-942-078-001; Roche; Basel, Switzerland), and 100 ml deoxyribonu-
clease II (D8764; Sigma-Aldrich). Following, the tissue was dispersed in a small
volume of culture medium (typically 150–200 ml) and plated onto conconavalin
A-coated coverslips. Cells were kept in a 32C incubator until use.
Calcium Imaging of Olfactory Sensory Neurons
Calcium imaging recordings were performed as described in detail elsewhere
(Araneda et al., 2004). Briefly, cells were rinsed with normal rat ringer (138 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 1.5 mM MgCl2, 10 mM HEPES, and 10 mM
glucose [pH 7.4]) and loaded with fura-2AM plus pluronic acid for 45 min at
room temperature. The coverslip was placed into a recording chamber and
imaged at room temperature at 380 nm excitation and 510 nm emission.
Due to the slow nature of the calcium response, images were only acquired
every 4 s with each image representing the average of three frames. NIH Image
software was used for data acquisition and analysis.
Ringer was continuously pumped through the recording chamber at a rate of
1 ml/min. Odorants were presented to the cells by injecting 400 ml of the stim-
ulus solution into the chamber over the course of 4 s, exchanging the volume of
the recording chamber two to three times. Odorants had been recently synthe-
sized and stored at 4C under inert atmosphere while awaiting testing. AllChemistry & Biology 15, 1317–1327, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1325
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Odorant Conformation and Receptor Activationodorants not specifically synthesized for this study were purchased from
Sigma-Aldrich. Stock solutions of the odorants in DMSO (0.5 M) were prepared
fresh daily. Stock solutions were subsequently diluted in Ringer to the indi-
cated concentrations with DMSO supplementation as necessary so that all
stimuli were matched for the amount of DMSO; cells did not respond to
DMSO alone at this level. Odorants were typically applied 3.25 min apart
with the exception of the panel screening in Figure 6, where spacing was
increased to 5 min apart. Because the cells shown in Figure 6 all likely express
different ORs, the adenylate cyclase activator forskolin (10 mM) was applied at
the end of the series to strongly stimulate the downstream signal transduction
path and thus provide a means of comparing responses between cells. The
response to forskolin also serves as a measure of the functional viability of
an OSN because adenylyl cyclase III, like the ORs, is localized to the cilia.
Data are shown as the fractional change in fluorescent light intensity,
(F-F0)/F0, where F is the fluorescent light intensity at each point and F0 is
the value for the emitted fluorescent light at the start of each movie before
the first stimulus application. Responses were measured between the baseline
and peak DF/F change. To account for drift due to alterations in fluid level or
incomplete return of intracellular calcium levels, flanking normalization stimuli
(typically C8 or compound 1 at 10 mM) were applied at the beginning and end of
each movie. A trend line could then be drawn between the peak responses of
the flanking applications. Responses to intervening odorants were normalized
by taking the ratio of the measured magnitude over the predicted (to trend line)
magnitude. Measured in this manner, we found repetitions of the same stimuli
meet or exceed 0.90. Accordingly, for the tuning choice in Figure 6A, we clas-
sified two responses as being effectively the same magnitude if they were
within 90% of each other, and in Figure 5D the combination of a putative antag-
onist with C8 needed to be less than 90% that of C8 alone to be classed as an
antagonist. Values for the antagonist ratio reported in Figure 5D represent the
average ± SEM. Dose response curves were fit using the Hill function in Igor
Pro with each point plotted as the average value from at least three indepen-
dent GFP-expressing cells ± SEM. EC50 and IC50 values are reported as ± SD.
For marginally activating aldehydes (C6 and compound 4), EC50 values are
extrapolated from the best fit curve.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
Supplemental References and can be found with this article online at http://
www.cell.com/chemistry-biology/supplemental/S1074-5521(08)00410-9.
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